Next Article in Journal
A New Era in Cardiogenetics
Previous Article in Journal
Genetic Testing for Hypertrophic Cardiomyopathy: Ongoing Voyage from Exploration to Clinical Exploitation
Cardiogenetics is published by MDPI from Volume 10 Issue 2 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Article

Tafazzin Gene Mutations Are Uncommon Causes of Dilated Cardiomyopathy in Adults

1
University of Colorado Denver, Aurora, CO, USA
2
Ospedale Cattinara and University of Trieste, Trieste, Italy
*
Author to whom correspondence should be addressed.
Cardiogenetics 2011, 1(1), 9-12; https://doi.org/10.4081/cardiogenetics.2011.e4
Received: 18 March 2011 / Revised: 18 March 2011 / Accepted: 9 June 2011 / Published: 5 July 2011
Barth syndrome is an X-linked genetic condition featuring neutropenia, skeletal myopathy, and dilated cardiomyopathy in boys due to tafazzin (TAZ) mutations. Pure dilated cardiomyopathy without other features of Barth syndrome may also result from TAZ mutations and survival into adulthood has been described. Although TAZ testing is routinely included in dilated cardiomyopathy panels in adults, the prevalence of TAZ mutations in the adult population, including women who may be at risk to develop later onset disease due to TAZ mutations, has not been measured. We screened 292 families with dilated cardiomyopathy (209 male and 83 female probands) for TAZ mutations using denaturing high-performance liquid chromatography and sequence analysis. Putative mutations were evaluated based on standard criteria including screening available relatives and healthy controls and for effects on splicing efficiency in the case of one intronic variant. Two variants suspicious for being pathogenic were found in two unrelated families (c.387T>C, Phe128Ser and c.507C>T, Leu169Leu). The Phe128Ser variant had been previously reported as a pathogenic mutation; however we determined that this variant is instead a rare polymorphism restricted to African Americans. The Leu169Leu variant was detected in a male patient and altered RNA processing in our minigene assay supporting a pathogenic role. No mutations in female subjects were detected. Tafazzin mutations were rare in our population of adults with dilated cardiomyopathy and none were found in females. Our findings indicate that genetic testing for tafazzin should not be routinely performed in dilated cardiomyopathy as suggested by current guidelines. Furthermore, the Phe128Ser variant is not pathogenic, but likely represents a benign polymorphism in persons of African American ancestry.
Keywords: dilated cardiomyopathy; tafazzin; genetics; Barth syndrome; neutropenia; genetic counseling dilated cardiomyopathy; tafazzin; genetics; Barth syndrome; neutropenia; genetic counseling
MDPI and ACS Style

Taylor, M.; Slavov, D.; Salcedo, E.; Zhu, X.; Ferguson, D.; Jirikowic, J.; Di Lenarda, A.; Sinagra, G.; Mestroni, L. Tafazzin Gene Mutations Are Uncommon Causes of Dilated Cardiomyopathy in Adults. Cardiogenetics 2011, 1, 9-12. https://doi.org/10.4081/cardiogenetics.2011.e4

AMA Style

Taylor M, Slavov D, Salcedo E, Zhu X, Ferguson D, Jirikowic J, Di Lenarda A, Sinagra G, Mestroni L. Tafazzin Gene Mutations Are Uncommon Causes of Dilated Cardiomyopathy in Adults. Cardiogenetics. 2011; 1(1):9-12. https://doi.org/10.4081/cardiogenetics.2011.e4

Chicago/Turabian Style

Taylor, Matthew, Dobromir Slavov, Ernesto Salcedo, Xiao Zhu, Deborah Ferguson, Jean Jirikowic, Andrea Di Lenarda, Gianfranco Sinagra, and Luisa Mestroni. 2011. "Tafazzin Gene Mutations Are Uncommon Causes of Dilated Cardiomyopathy in Adults" Cardiogenetics 1, no. 1: 9-12. https://doi.org/10.4081/cardiogenetics.2011.e4

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop